Canada Pension Plan Investment Board Grows Stock Position in Harrow, Inc. (NASDAQ:HROW)

Canada Pension Plan Investment Board lifted its stake in Harrow, Inc. (NASDAQ:HROW - Free Report) by 10,500.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 42,400 shares of the company's stock after purchasing an additional 42,000 shares during the quarter. Canada Pension Plan Investment Board owned about 0.12% of Harrow worth $1,423,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of HROW. AlphaQuest LLC grew its position in Harrow by 452.8% in the fourth quarter. AlphaQuest LLC now owns 3,527 shares of the company's stock worth $118,000 after acquiring an additional 2,889 shares during the period. Virtu Financial LLC acquired a new stake in shares of Harrow in the third quarter valued at $271,000. Federated Hermes Inc. acquired a new position in shares of Harrow during the fourth quarter worth about $214,000. Maridea Wealth Management LLC acquired a new stake in shares of Harrow in the 4th quarter valued at $222,000. Finally, KLP Kapitalforvaltning AS purchased a new stake in Harrow during the fourth quarter worth approximately $235,000. Hedge funds and other institutional investors own 72.76% of the company's stock.

Analysts Set New Price Targets

Several analysts recently commented on HROW shares. HC Wainwright reiterated a "buy" rating and issued a $57.00 price target on shares of Harrow in a research report on Monday, March 31st. B. Riley decreased their price target on Harrow from $69.00 to $65.00 and set a "buy" rating on the stock in a research note on Tuesday, April 1st.

Harrow Price Performance

Harrow stock traded down $0.02 during mid-day trading on Tuesday, hitting $24.63. 47,853 shares of the company were exchanged, compared to its average volume of 457,560. Harrow, Inc. has a 12-month low of $10.04 and a 12-month high of $59.23. The company has a market capitalization of $878.16 million, a P/E ratio of -26.20 and a beta of 0.46. The business's 50 day simple moving average is $25.36 and its two-hundred day simple moving average is $34.43. The company has a debt-to-equity ratio of 3.23, a current ratio of 1.55 and a quick ratio of 1.44.

Harrow (NASDAQ:HROW - Get Free Report) last announced its earnings results on Thursday, March 27th. The company reported $0.25 earnings per share for the quarter, beating the consensus estimate of $0.11 by $0.14. Harrow had a negative net margin of 19.75% and a negative return on equity of 45.57%. The firm had revenue of $66.83 million during the quarter, compared to the consensus estimate of $66.01 million. Analysts forecast that Harrow, Inc. will post -0.53 earnings per share for the current fiscal year.

Harrow Company Profile

Harrow, Inc operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company was formerly known as Imprimis Pharmaceuticals, Inc and changed its name to Harrow Health, Inc in December 2018. Harrow Health, Inc was incorporated in 2006 and is headquartered in Nashville, Tennessee.